$343.29
-3.11-0.90%
At close: -
$343.29
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Madrigal Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:MDGL | Benzinga
Madrigal Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 6
EPS Estimate
$-3.830
Quarterly Revenue Estimate
$97.00M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$180.13M
Analyze the earnings history of Madrigal Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MDGL | Madrigal Pharmaceuticals | -$7.38 | -$3.83 | — | — | $0.00 | $97.00M | — | — | 05/06/2025 | Get Alert |
| MDGL | Madrigal Pharmaceuticals | -$5.68 | -$4.12 | -$2.71 | 34.22% | $0.00 | $91.25M | $103.32M | 13.23% | 02/26/2025 | Get Alert |
| MDGL | Madrigal Pharmaceuticals | -$5.34 | -$6.91 | -$4.92 | 28.80% | $0.00 | $34.19M | $62.17M | 81.85% | 10/31/2024 | Get Alert |
| MDGL | Madrigal Pharmaceuticals | -$4.69 | -$7.54 | -$7.10 | 5.84% | $0.00 | $4.02M | $14.64M | 264.13% | 08/07/2024 | Get Alert |
| MDGL | Madrigal Pharmaceuticals | -$4.23 | -$6.28 | -$7.38 | -17.52% | $0.00 | — | $0.00 | — | 05/07/2024 | Get Alert |
| MDGL | Madrigal Pharmaceuticals | -$4.98 | -$5.28 | -$5.68 | -7.58% | $0.00 | — | $0.00 | — | 02/28/2024 | Get Alert |
| MDGL | Madrigal Pharmaceuticals | -$4.75 | -$4.92 | -$5.34 | -8.54% | $0.00 | — | $0.00 | — | 11/06/2023 | Get Alert |
| MDGL | Madrigal Pharmaceuticals | -$4.14 | -$4.58 | -$4.69 | -2.40% | $0.00 | — | $0.00 | — | 08/08/2023 | Get Alert |
| MDGL | Madrigal Pharmaceuticals | -$3.36 | -$4.94 | -$4.23 | 14.37% | $0.00 | — | $0.00 | — | 05/09/2023 | Get Alert |
| MDGL | Madrigal Pharmaceuticals | -$3.78 | -$4.56 | -$4.98 | -9.21% | $0.00 | — | $0.00 | — | 02/23/2023 | Get Alert |
| MDGL | Madrigal Pharmaceuticals | -$3.79 | -$4.15 | -$4.75 | -14.46% | $0.00 | — | $0.00 | — | 11/03/2022 | Get Alert |
| MDGL | Madrigal Pharmaceuticals | -$3.72 | -$3.75 | -$4.14 | -10.40% | $0.00 | — | $0.00 | — | 08/04/2022 | Get Alert |
| MDGL | Madrigal Pharmaceuticals | -$3.32 | -$3.62 | -$3.36 | 7.18% | $0.00 | — | $0.00 | — | 05/09/2022 | Get Alert |
| MDGL | Madrigal Pharmaceuticals | -$3.82 | -$3.88 | -$3.78 | 2.58% | $0.00 | — | $0.00 | — | 02/24/2022 | Get Alert |
| MDGL | Madrigal Pharmaceuticals | -$3.75 | -$3.90 | -$3.79 | 2.82% | $0.00 | — | $0.00 | — | 11/04/2021 | Get Alert |
| MDGL | Madrigal Pharmaceuticals | -$3.18 | -$3.59 | -$3.72 | -3.62% | $0.00 | — | $0.00 | — | 08/05/2021 | Get Alert |
| MDGL | Madrigal Pharmaceuticals | -$2.34 | -$3.85 | -$3.32 | 13.77% | $0.00 | — | $0.00 | — | 05/06/2021 | Get Alert |
| MDGL | Madrigal Pharmaceuticals | -$1.80 | — | -$3.82 | — | $0.00 | — | $0.00 | — | 02/25/2021 | Get Alert |
| MDGL | Madrigal Pharmaceuticals | -$1.39 | — | -$3.75 | — | $0.00 | — | $0.00 | — | 11/05/2020 | Get Alert |
| MDGL | Madrigal Pharmaceuticals | -$1.28 | — | -$3.18 | — | $0.00 | — | $0.00 | — | 08/06/2020 | Get Alert |
| MDGL | Madrigal Pharmaceuticals | -$0.98 | — | -$2.34 | — | $0.00 | — | $0.00 | — | 05/07/2020 | Get Alert |
Madrigal Pharmaceuticals (MDGL) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-26 | $-2.71 | $-4.12 | 34.2 % |
| Q3 | 2024-10-31 | $-4.92 | $-6.91 | 28.8 % |
| Q2 | 2024-08-07 | $-7.10 | $-7.54 | 5.84 % |
| Q1 | 2024-05-07 | $-7.38 | $-6.28 | -17.5 % |
Madrigal Pharmaceuticals (MDGL) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-26 | $103.32M | $91.25M | 13.2 % |
| Q3 | 2024-10-31 | $62.18M | $34.19M | 81.8 % |
| Q2 | 2024-08-07 | $14.64M | $4.02M | 264.1 % |
FAQ
When is Madrigal Pharmaceuticals (NASDAQ:MDGL) reporting earnings?
Madrigal Pharmaceuticals (MDGL) is scheduled to report earnings on May 6, 2025. The last reported earnings were for reported on February 26, 2025 for Q4.
What were the latest earnings per share (EPS) for Madrigal Pharmaceuticals (NASDAQ:MDGL)?
The Actual EPS was $-2.71, which beat the estimate of $-4.12.
What were Madrigal Pharmaceuticals’s (NASDAQ:MDGL) revenues?
The Actual Revenue was $103.3M, which beat the estimate of $91.3M.
Browse earnings estimates, EPS, and revenue on all stocks.